As high levels of IL6 have been reported in the microenvironment of several tumor types including breast carcinomas [38] with a poor prognosis, current studies focus on the use of such molecules as JAK-STAT pathway modulators in cancer treatment. The gene discussed is IL6; the disease is cancer.